Cargando…

Designing malaria vaccines to circumvent antigen variability()

Prospects for malaria eradication will be greatly enhanced by an effective vaccine, but parasite genetic diversity poses a major impediment to malaria vaccine efficacy. In recent pre-clinical and field trials, vaccines based on polymorphic Plasmodium falciparum antigens have shown efficacy only agai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ouattara, Amed, Barry, Alyssa E., Dutta, Sheetij, Remarque, Edmond J., Beeson, James G., Plowe, Christopher V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731100/ https://www.ncbi.nlm.nih.gov/pubmed/26475447 http://dx.doi.org/10.1016/j.vaccine.2015.09.110

Ejemplares similares

An In Silico Analysis of Malaria Pre-Erythrocytic-Stage Antigens Interpreting Worldwide Genetic Data to Suggest Vaccine Candidate Variants and Epitopes
por: Ouattara, Amed, et al.
Publicado: (2022)

Dynamics of Polymorphism in a Malaria Vaccine Antigen at a Vaccine-Testing Site in Mali
por: Takala, Shannon L, et al.
Publicado: (2007)

Strategies for Designing and Monitoring Malaria Vaccines Targeting Diverse Antigens
por: Barry, Alyssa E., et al.
Publicado: (2014)

Lack of allele-specific efficacy of a bivalent AMA1 malaria vaccine
por: Ouattara, Amed, et al.
Publicado: (2010)

Overcoming Antigenic Diversity by Enhancing the Immunogenicity of Conserved Epitopes on the Malaria Vaccine Candidate Apical Membrane Antigen-1
por: Dutta, Sheetij, et al.
Publicado: (2013)

Correction: Overcoming Antigenic Diversity by Enhancing the Immunogenicity of Conserved Epitopes on the Malaria Vaccine Candidate Apical Membrane Antigen-1
por: Dutta, Sheetij, et al.
Publicado: (2014)

Protective antibody threshold of RTS,S/AS01 malaria vaccine correlates antigen and adjuvant dose in mouse model
por: Genito, Christopher J., et al.
Publicado: (2023)

Immunoglobulin G subclass and antibody avidity responses in Malian children immunized with Plasmodium falciparum apical membrane antigen 1 vaccine candidate FMP2.1/AS02(A)
por: Berry, Andrea A., et al.
Publicado: (2019)

Designing a therapeutic hepatitis B vaccine to circumvent immune tolerance
por: Whitacre, DC, et al.
Publicado: (2019)

Limited antigenic diversity of Plasmodium falciparum apical membrane antigen 1 supports the development of effective multi-allele vaccines
por: Terheggen, Ulrich, et al.
Publicado: (2014)

Microarray analyses reveal strain-specific antibody responses to Plasmodium falciparum apical membrane antigen 1 variants following natural infection and vaccination
por: Bailey, Jason A., et al.
Publicado: (2020)

Variation in the Circumsporozoite Protein of Plasmodium falciparum: Vaccine Development Implications
por: Gandhi, Kavita, et al.
Publicado: (2014)

Extent and Dynamics of Polymorphism in the Malaria Vaccine Candidate Plasmodium falciparum Reticulocyte–Binding Protein Homologue-5 in Kalifabougou, Mali
por: Ouattara, Amed, et al.
Publicado: (2018)

Measurement of the plasma levels of antibodies against the polymorphic vaccine candidate apical membrane antigen 1 in a malaria-exposed population
por: Kusi, Kwadwo A, et al.
Publicado: (2012)

Correction: Variation in the Circumsporozoite Protein of Plasmodium falciparum: Vaccine Development Implications
por: Gandhi, Kavita, et al.
Publicado: (2016)

Circumventing the Greatwall
por: Short, Ben
Publicado: (2014)

Defining species-specific and conserved interactions of apical membrane protein 1 during erythrocyte invasion in malaria to inform multi-species vaccines
por: Drew, Damien R., et al.
Publicado: (2023)

Surface antigens of Plasmodium falciparum-infected erythrocytes as immune targets and malaria vaccine candidates
por: Chan, Jo-Anne, et al.
Publicado: (2014)

A Malaria Vaccine Adjuvant Based on Recombinant Antigen Binding to Liposomes
por: Huang, Wei-Chiao, et al.
Publicado: (2018)

Blood Interferon Signatures Putatively Link Lack of Protection Conferred by the RTS,S Recombinant Malaria Vaccine to an Antigen-specific IgE Response
por: Rinchai, Darawan, et al.
Publicado: (2017)

Impact of the RTS,S Malaria Vaccine Candidate on Naturally Acquired Antibody Responses to Multiple Asexual Blood Stage Antigens
por: Campo, Joseph J., et al.
Publicado: (2011)

Smarter vaccine design will circumvent regulatory T cell-mediated evasion in chronic HIV and HCV infection
por: Moise, Leonard, et al.
Publicado: (2014)

Oral antigen exposure in newborn piglets circumvents induction of oral tolerance in response to intraperitoneal vaccination in later life
por: Pasternak, J Alex, et al.
Publicado: (2015)

Children with cerebral malaria or severe malarial anaemia lack immunity to distinct variant surface antigen subsets
por: Travassos, Mark A., et al.
Publicado: (2018)

Differential Patterns of IgG Subclass Responses to Plasmodium falciparum Antigens in Relation to Malaria Protection and RTS,S Vaccination
por: Dobaño, Carlota, et al.
Publicado: (2019)

Polymorphisms in Fc Gamma Receptors and Susceptibility to Malaria in an Endemic Population
por: Amiah, Mireille Ahou, et al.
Publicado: (2020)

Prevalence and patterns of antifolate and chloroquine drug resistance markers in Plasmodium vivax across Pakistan
por: Khattak, Aamer A, et al.
Publicado: (2013)

A novel method for extracting nucleic acids from dried blood spots for ultrasensitive detection of low-density Plasmodium falciparum and Plasmodium vivax infections
por: Zainabadi, Kayvan, et al.
Publicado: (2017)

Malaria chemoprevention and drug resistance: a review of the literature and policy implications
por: Plowe, Christopher V.
Publicado: (2022)

A novel approach to identifying patterns of human invasion-inhibitory antibodies guides the design of malaria vaccines incorporating polymorphic antigens
por: Drew, Damien R., et al.
Publicado: (2016)

Antigen-Specific B Memory Cell Responses to Plasmodium falciparum Malaria Antigens and Schistosoma haematobium Antigens in Co-Infected Malian Children
por: Lyke, Kirsten E., et al.
Publicado: (2012)

Towards a Vaccine against Plasmodium vivax Malaria
por: Beeson, James G, et al.
Publicado: (2007)

Vaccine-induced Immunity Circumvented by Typical Mycobacterium tuberculosis Beijing Strains
por: Kremer, Kristin, et al.
Publicado: (2009)

Plasmodium berghei Circumvents Immune Responses Induced by Merozoite Surface Protein 1- and Apical Membrane Antigen 1-Based Vaccines
por: Yoshida, Shigeto, et al.
Publicado: (2010)

Safety and immunogenicity of multi-antigen AMA1-based vaccines formulated with CoVaccine HT™ and Montanide ISA 51 in rhesus macaques
por: Kusi, Kwadwo A, et al.
Publicado: (2011)

Conformational Dynamics and Antigenicity in the Disordered Malaria Antigen Merozoite Surface Protein 2
por: MacRaild, Christopher A., et al.
Publicado: (2015)

Defining the Antigenic Diversity of Plasmodium falciparum Apical Membrane Antigen 1 and the Requirements for a Multi-Allele Vaccine against Malaria
por: Drew, Damien R., et al.
Publicado: (2012)

Estimating the proportion of resistance alleles from bulk Sanger sequencing, circumventing the variability of individual DNA
por: Sudo, Masaaki, et al.
Publicado: (2021)

Genetic diversity and drug resistance surveillance of Plasmodium falciparum for malaria elimination: is there an ideal tool for resource-limited sub-Saharan Africa?
por: Apinjoh, Tobias O., et al.
Publicado: (2019)

Strain-specific Plasmodium falciparum growth inhibition among Malian children immunized with a blood-stage malaria vaccine
por: Laurens, Matthew B., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0um1m5gbbi3v2o1hbp72d4uuok